Although Ng is primarily known to be an AD-specific biomarker, we found that Ng levels, compared to SCD patients, were also significantly elevated in both AD and FTD patients but failed to significantly distinguish these two clinical groups. The gene discussed is NRGN; the disease is Schnyder corneal dystrophy.